Bacterial Vaginosis Treatment
Bacterial Vaginosis Treatment market is segmented by players, region (country), by Type and by Ap ... Read More
Global Infectious Disease Point of Care Diagnostics Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Over-the-counter (OTC) Testing Kits
1.2.3 Prescription-based Testing Kits
1.3 Market by Application
1.3.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Bacterial Infections
1.3.3 Fungal Infection
1.3.4 Virus Infection
1.3.5 Cardiovascular Infection
1.3.6 Gastrointestinal Infection
1.3.7 Sexually Transmitted Disease (STD) Infection
1.3.8 Central Nervous System Infection
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Point of Care Diagnostics Market Perspective (2017-2028)
2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Region
2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Infectious Disease Point of Care Diagnostics Market Dynamics
2.3.1 Infectious Disease Point of Care Diagnostics Industry Trends
2.3.2 Infectious Disease Point of Care Diagnostics Market Drivers
2.3.3 Infectious Disease Point of Care Diagnostics Market Challenges
2.3.4 Infectious Disease Point of Care Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue
3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
3.4 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2021
3.5 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
3.6 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
3.7 Date of Enter into Infectious Disease Point of Care Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Point of Care Diagnostics Breakdown Data by Type
4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2023-2028)
5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application
5.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
6.2 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
9.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
11.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 Siemens
11.2.1 Siemens Company Detail
11.2.2 Siemens Business Overview
11.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
11.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.2.5 Siemens Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
11.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.3.5 GE Healthcare Recent Development
11.4 Accriva
11.4.1 Accriva Company Detail
11.4.2 Accriva Business Overview
11.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
11.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.4.5 Accriva Recent Development
11.5 Terumo
11.5.1 Terumo Company Detail
11.5.2 Terumo Business Overview
11.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
11.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.5.5 Terumo Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Detail
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
11.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.6.5 BioMerieux Recent Development
11.7 Diasorin
11.7.1 Diasorin Company Detail
11.7.2 Diasorin Business Overview
11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
11.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.7.5 Diasorin Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
11.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.8.5 Roche Recent Development
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Detail
11.9.2 Danaher Corporation Business Overview
11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
11.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.9.5 Danaher Corporation Recent Development
11.10 BD
11.10.1 BD Company Detail
11.10.2 BD Business Overview
11.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
11.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.10.5 BD Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
11.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Cavidi
11.12.1 Cavidi Company Detail
11.12.2 Cavidi Business Overview
11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
11.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.12.5 Cavidi Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Detail
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
11.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.13.5 Cepheid Recent Development
11.14 Diaxonhit
11.14.1 Diaxonhit Company Detail
11.14.2 Diaxonhit Business Overview
11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
11.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.14.5 Diaxonhit Recent Development
11.15 Eiken Chemical
11.15.1 Eiken Chemical Company Detail
11.15.2 Eiken Chemical Business Overview
11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
11.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.15.5 Eiken Chemical Recent Development
11.16 EMD Millipore
11.16.1 EMD Millipore Company Detail
11.16.2 EMD Millipore Business Overview
11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
11.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.16.5 EMD Millipore Recent Development
11.17 Epitope Diagnostic
11.17.1 Epitope Diagnostic Company Detail
11.17.2 Epitope Diagnostic Business Overview
11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
11.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.17.5 Epitope Diagnostic Recent Development
11.18 Euroimmun
11.18.1 Euroimmun Company Detail
11.18.2 Euroimmun Business Overview
11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
11.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.18.5 Euroimmun Recent Development
11.19 Gold Standard Diagnostics
11.19.1 Gold Standard Diagnostics Company Detail
11.19.2 Gold Standard Diagnostics Business Overview
11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
11.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.19.5 Gold Standard Diagnostics Recent Development
11.20 Hologic
11.20.1 Hologic Company Detail
11.20.2 Hologic Business Overview
11.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
11.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.20.5 Hologic Recent Development
11.21 Immunetics
11.21.1 Immunetics Company Detail
11.21.2 Immunetics Business Overview
11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
11.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.21.5 Immunetics Recent Development
11.22 InBios International
11.22.1 InBios International Company Detail
11.22.2 InBios International Business Overview
11.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
11.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
11.22.5 InBios International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Over-the-counter (OTC) Testing Kits
Table 3. Key Players of Prescription-based Testing Kits
Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Infectious Disease Point of Care Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Infectious Disease Point of Care Diagnostics Market Share by Region (2017-2022)
Table 8. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Infectious Disease Point of Care Diagnostics Market Share by Region (2023-2028)
Table 10. Infectious Disease Point of Care Diagnostics Market Trends
Table 11. Infectious Disease Point of Care Diagnostics Market Drivers
Table 12. Infectious Disease Point of Care Diagnostics Market Challenges
Table 13. Infectious Disease Point of Care Diagnostics Market Restraints
Table 14. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Infectious Disease Point of Care Diagnostics Market Share by Players (2017-2022)
Table 16. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2021)
Table 17. Ranking of Global Top Infectious Disease Point of Care Diagnostics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Infectious Disease Point of Care Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
Table 21. Date of Enter into Infectious Disease Point of Care Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2017-2022)
Table 25. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2023-2028)
Table 27. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2017-2022)
Table 29. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2023-2028)
Table 31. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Abbott Company Detail
Table 42. Abbott Business Overview
Table 43. Abbott Infectious Disease Point of Care Diagnostics Product
Table 44. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 45. Abbott Recent Development
Table 46. Siemens Company Detail
Table 47. Siemens Business Overview
Table 48. Siemens Infectious Disease Point of Care Diagnostics Product
Table 49. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 50. Siemens Recent Development
Table 51. GE Healthcare Company Detail
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Infectious Disease Point of Care Diagnostics Product
Table 54. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Accriva Company Detail
Table 57. Accriva Business Overview
Table 58. Accriva Infectious Disease Point of Care Diagnostics Product
Table 59. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 60. Accriva Recent Development
Table 61. Terumo Company Detail
Table 62. Terumo Business Overview
Table 63. Terumo Infectious Disease Point of Care Diagnostics Product
Table 64. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 65. Terumo Recent Development
Table 66. BioMerieux Company Detail
Table 67. BioMerieux Business Overview
Table 68. BioMerieux Infectious Disease Point of Care Diagnostics Product
Table 69. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 70. BioMerieux Recent Development
Table 71. Diasorin Company Detail
Table 72. Diasorin Business Overview
Table 73. Diasorin Infectious Disease Point of Care Diagnostics Product
Table 74. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 75. Diasorin Recent Development
Table 76. Roche Company Detail
Table 77. Roche Business Overview
Table 78. Roche Infectious Disease Point of Care Diagnostics Product
Table 79. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Danaher Corporation Company Detail
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Infectious Disease Point of Care Diagnostics Product
Table 84. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 85. Danaher Corporation Recent Development
Table 86. BD Company Detail
Table 87. BD Business Overview
Table 88. BD Infectious Disease Point of Care Diagnostics Product
Table 89. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 90. BD Recent Development
Table 91. Bio-Rad Laboratories Company Detail
Table 92. Bio-Rad Laboratories Business Overview
Table 93. Bio-Rad Laboratories Infectious Disease Point of Care DiagnosticsProduct
Table 94. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 95. Bio-Rad Laboratories Recent Development
Table 96. Cavidi Company Detail
Table 97. Cavidi Business Overview
Table 98. Cavidi Infectious Disease Point of Care DiagnosticsProduct
Table 99. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 100. Cavidi Recent Development
Table 101. Cepheid Company Detail
Table 102. Cepheid Business Overview
Table 103. Cepheid Infectious Disease Point of Care DiagnosticsProduct
Table 104. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 105. Cepheid Recent Development
Table 106. Diaxonhit Company Detail
Table 107. Diaxonhit Business Overview
Table 108. Diaxonhit Infectious Disease Point of Care DiagnosticsProduct
Table 109. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 110. Diaxonhit Recent Development
Table 111. Eiken Chemical Company Detail
Table 112. Eiken Chemical Business Overview
Table 113. Eiken Chemical Infectious Disease Point of Care DiagnosticsProduct
Table 114. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 115. Eiken Chemical Recent Development
Table 116. EMD Millipore Company Detail
Table 117. EMD Millipore Business Overview
Table 118. EMD Millipore Infectious Disease Point of Care DiagnosticsProduct
Table 119. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 120. EMD Millipore Recent Development
Table 121. Epitope Diagnostic Company Detail
Table 122. Epitope Diagnostic Business Overview
Table 123. Epitope Diagnostic Infectious Disease Point of Care DiagnosticsProduct
Table 124. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 125. Epitope Diagnostic Recent Development
Table 126. Euroimmun Company Detail
Table 127. Euroimmun Business Overview
Table 128. Euroimmun Infectious Disease Point of Care DiagnosticsProduct
Table 129. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 130. Euroimmun Recent Development
Table 131. Gold Standard Diagnostics Company Detail
Table 132. Gold Standard Diagnostics Business Overview
Table 133. Gold Standard Diagnostics Infectious Disease Point of Care DiagnosticsProduct
Table 134. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 135. Gold Standard Diagnostics Recent Development
Table 136. Hologic Company Detail
Table 137. Hologic Business Overview
Table 138. Hologic Infectious Disease Point of Care DiagnosticsProduct
Table 139. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 140. Hologic Recent Development
Table 141. Immunetics Company Detail
Table 142. Immunetics Business Overview
Table 143. Immunetics Infectious Disease Point of Care DiagnosticsProduct
Table 144. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 145. Immunetics Recent Development
Table 146. InBios International Company Detail
Table 147. InBios International Business Overview
Table 148. InBios International Infectious Disease Point of Care DiagnosticsProduct
Table 149. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
Table 150. InBios International Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Over-the-counter (OTC) Testing Kits Features
Figure 3. Prescription-based Testing Kits Features
Figure 4. Global Infectious Disease Point of Care Diagnostics Market Share by Application in 2021 & 2028
Figure 5. Bacterial Infections Case Studies
Figure 6. Fungal Infection Case Studies
Figure 7. Virus Infection Case Studies
Figure 8. Cardiovascular Infection Case Studies
Figure 9. Gastrointestinal Infection Case Studies
Figure 10. Sexually Transmitted Disease (STD) Infection Case Studies
Figure 11. Central Nervous System Infection Case Studies
Figure 12. Other Case Studies
Figure 13. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 14. Global Infectious Disease Point of Care Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Infectious Disease Point of Care Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Infectious Disease Point of Care Diagnostics Market Share by Region: 2021 VS 2028
Figure 17. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2021
Figure 18. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2021
Figure 20. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Infectious Disease Point of Care Diagnostics Market Share by Country (2017-2028)
Figure 22. United States Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Infectious Disease Point of Care Diagnostics Market Share by Country (2017-2028)
Figure 26. Germany Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Region (2017-2028)
Figure 34. China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Infectious Disease Point of Care Diagnostics Market Share by Country (2017-2028)
Figure 42. Mexico Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Country (2017-2028)
Figure 46. Turkey Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 49. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 50. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 51. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 52. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 53. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 54. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 55. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 56. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 57. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 59. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 60. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 61. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 62. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 63. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 64. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 65. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 66. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 67. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 68. Immunetics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 69. InBios International Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Siemens GE Healthcare Accriva Terumo BioMerieux Diasorin Roche Danaher Corporation BD Bio-Rad Laboratories Cavidi Cepheid Diaxonhit Eiken Chemical EMD Millipore Epitope Diagnostic Euroimmun Gold Standard Diagnostics Hologic Immunetics InBios International